[4-(2-cyclopentyloxyanilino)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-6-yl]-(4-methylpiperazin-1-yl)methanone
C27H34N6O2 — CID 118062525
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-(2-cyclopentyloxyanilino)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-6-yl]-(4-methylpiperazin-1-yl)methanone
[4-(2-cyclopentyloxyanilino)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-6-yl]-(4-methylpiperazin-1-yl)methanone (PubChem CID 118062525) has the molecular formula C27H34N6O2 and a molecular weight of 474.61 g/mol. Its IUPAC name is [4-(2-cyclopentyloxyanilino)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-6-yl]-(4-methylpiperazin-1-yl)methanone.
Molecular Properties
| Compound Name | [4-(2-cyclopentyloxyanilino)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-6-yl]-(4-methylpiperazin-1-yl)methanone |
|---|---|
| PubChem CID | 118062525 |
| Molecular Formula | C27H34N6O2 |
| Molecular Weight | 474.61 g/mol |
| Exact Mass | 474.27 |
| IUPAC Name | [4-(2-cyclopentyloxyanilino)-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b]indol-6-yl]-(4-methylpiperazin-1-yl)methanone |
| SMILES | CN1CCN(C(=O)C2CCc3[nH]c4ncnc(Nc5ccccc5OC5CCCC5)c4c3C2)CC1 |
| InChI | InChI=1S/C27H34N6O2/c1-32-12-14-33(15-13-32)27(34)18-10-11-21-20(16-18)24-25(30-21)28-17-29-26(24)31-22-8-4-5-9-23(22)35-19-6-2-3-7-19/h4-5,8-9,17-19H,2-3,6-7,10-16H2,1H3,(H2,28,29,30,31) |
| InChIKey | VKXCSXLMABEJRO-UHFFFAOYSA-N |
| XLogP | 3.90 |
| TPSA | 86.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 474.61 |
| LogP ≤ 5 | 3.90 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118062525 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.